arrow
P

Paolo Radice

irccs european institute of oncology (ieo)
H指数:91
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The APC I1307K variant and male breast cancer risk: a multicenter case-control study in Italy

APC I1307K变异与男性乳腺癌风险:一项意大利多中心病例对照研究

2025-12-010
OAAI
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

398,238名女性的全基因组关联研究揭示了七个与高级别浆液性卵巢癌相关的位点

2025-11-200
OAAI
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer

大规模元分析和精确功能测定识别出FANCM区域,其中致病性体细胞突变(PTVs)对ER阴性和三阴性乳腺癌产生不同的风险。

2025-10-300
OAAI
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel
2024-09-0112
OAAI
Understanding the genetic complexity of puberty timing across the allele frequency spectrum

了解等位基因频谱中青春期时间的遗传复杂性

2024-07-013
OAAI
Integration of functional data to classify BRCA1/2 missense variants: An ENIGMA project
2024-03-220
PRE
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study

男性乳腺癌风险与BRCA1/2以外基因的致病变异相关: 一项意大利病例对照研究

2023-07-017
OAAI
Don't get lost in translation: Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) recommendations for reporting germline cancer susceptibility gene variants in 19 languages - breast cancer as a model
2023-03-010
PRE
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach

临床,剪接和功能分析以分类BRCA2外显子3变体: 基于点的ACMG/AMP方法的应用

2022-10-236
OAAI